These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 3471179

  • 41. Pharmacokinetics of nomifensine in impaired renal function.
    Ringoir S, Lameire N, Munche M, Heptner W, Taeuber K.
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):129S-134S. PubMed ID: 334214
    [Abstract] [Full Text] [Related]

  • 42. Pharmacokinetics of ofloxacin. An overview.
    Flor S.
    Am J Med; 1989 Dec 29; 87(6C):24S-30S. PubMed ID: 2603892
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
    Wise R, Lister D, McNulty CA, Griggs D, Andrews JM.
    Infection; 1986 Dec 29; 14 Suppl 3():S196-202. PubMed ID: 3463542
    [Abstract] [Full Text] [Related]

  • 47. Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers.
    Thalhammer F, Kletzmayr J, El Menyawi I, Kovarik J, Rosenkranz AR, Traunmüller F, Hörl WH, Burgmann H.
    Am J Kidney Dis; 1998 Oct 29; 32(4):642-5. PubMed ID: 9774127
    [Abstract] [Full Text] [Related]

  • 48. Pharmacokinetics of lomefloxacin in renally compromised patients.
    Blum RA, Schultz RW, Schentag JJ.
    Antimicrob Agents Chemother; 1990 Dec 29; 34(12):2364-8. PubMed ID: 2088191
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Reduced production, absorption, and elimination of erythropoietin in uremia compared with healthy volunteers.
    Jensen JD, Madsen JK, Jensen LW, Pedersen EB.
    J Am Soc Nephrol; 1994 Aug 29; 5(2):177-85. PubMed ID: 7993997
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis.
    Orlando R, Sawadogo A, Miglioli PA, Cappellazzo MG, Palatini P.
    Chemotherapy; 1992 Aug 29; 38(1):1-6. PubMed ID: 1617997
    [Abstract] [Full Text] [Related]

  • 57. Moxalactam pharmacokinetics during hemodialysis.
    Aronoff GR, Sloan RS, Mong SA, Luft FC, Kleit SA.
    Antimicrob Agents Chemother; 1981 Apr 29; 19(4):575-7. PubMed ID: 6454386
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.